Insider · CIK 0001817890
Alexandra Diane Janet Mancini
Files at INM (InMed Pharmaceuticals Inc.). First filing Aug 2, 2024, latest Aug 2, 2024.
In brief
Alexandra Diane Janet Mancini files SEC Form 4 as officer at INM (InMed Pharmaceuticals Inc.). Since Aug 2, 2024, Alexandra Diane Janet Mancini has reported 0 open-market buys worth $0 and 1 open-market sell worth $42, the latest filed on Aug 2, 2024.
A track record needs three past buys with six months of prices behind them; Alexandra Diane Janet Mancini has 0, so none is measured yet.
The newest scored trade: sold $42 of INM on Jul 31, 2024, filed Aug 2, 2024, scored 28 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
INM: InMed Pharmaceuticals Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 28Weak | INMsell InMed Pharmaceuticals Inc. | $42 240 shares | -100% | 0% from low-83% from high |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 31, 2024 | INM InMed Pharmaceuticals Inc. | SOpen-market sale Common Stock | -240 | $0.18 | $42 | 0 | Aug 2, 2024 |
| May 27, 2024 | INM InMed Pharmaceuticals Inc. | HExpiration of long derivative Employee Stock Option (Expiration)derivative | -485 | $0.00 | $0 | 52,000 | May 28, 2024 |
| Jan 21, 2024 | INM InMed Pharmaceuticals Inc. | HExpiration of long derivative Employee Stock Option (Expiration)derivative | -121 | $0.00 | $0 | 52,485 | Mar 5, 2024 |
| Dec 23, 2023 | INM InMed Pharmaceuticals Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +45,000 | $0.00 | $0 | 52,606 | Dec 26, 2023 |
Questions about Alexandra Diane Janet Mancini
Answered from the filings on this page, as of the latest one.
Is Alexandra Diane Janet Mancini buying or selling?
Not in the last 12 months. Alexandra Diane Janet Mancini's latest open-market trade on SEC Form 4 was sold $42 of INM on Jul 31, 2024.
How did Alexandra Diane Janet Mancini's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Alexandra Diane Janet Mancini has 0.
Where does Alexandra Diane Janet Mancini file Form 4?
Alexandra Diane Janet Mancini has filed Form 4 at INM (InMed Pharmaceuticals Inc.) as Sr VP, Clinical Reg Affairs. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.